跳至主要内容
临床试验/EUCTR2016-002460-13-GB
EUCTR2016-002460-13-GB进行中(未招募)1 期

Effect of High-Dose Vitamin D3 on 28-Day Mortality in Adult Critically Ill Patients with Severe Vitamin D DeficiencyThe UK arm of an International Multi-Centre, Placebo-Controlled, Phase III Double-Blind trial - VITDALIZE UK

Medical Unviersity of Graz0 个研究点目标入组 2,400 人开始时间: 2020年9月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
2,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients =18 years
  • 2. Anticipated ICU stay = 48 hours
  • 3. Admission to ICU = 72 hours before screening for VDD
  • 4. Severe VDD (25(OH)D =12ng/ml (30nmol/L)) using either the hospital's clinical laboratory or rapid bedside testing after ICU admission
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 400
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • 1. Severe gastrointestinal dysfunction (>400ml nasogastric tube residual volume) /unable to receive trial medication
  • 2. Not expected to survive initial 48 hours of admission or treatment withdrawal imminent within 24 hours.
  • 3. Patient with DNAR (Do Not Attempt Resuscitation) orders in place
  • 4. Hypercalcemia (>2.65mmol/l corrected calcium and/or >1.35mmol/l ionized calcium at screening)
  • 5. Known kidney stones within the last 12 months
  • 6. Known active tuberculosis within the last 12 months
  • 7. Known sarcoidosis within the last 12 months
  • 8. Women of child bearing age who have tested positive for pregnancy or who are lactating
  • 9. Known hypersensitivity to the trial drug or excipient
  • 10. Medical team deem it not suitable to include patient
  • 11. Known prisoners in the custody of HM Prison and Probation services

研究者

发起方
Medical Unviersity of Graz

相似试验